Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neuropsychopharmacology ; 42(6): 1315-1325, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-27748741

RESUMO

Attentional impairments and exaggerated impulsivity are key features of psychiatric disorders, such as attention-deficit/hyperactivity disorder, schizophrenia, and addiction. These deficits in attentional performance and impulsive behaviors have been associated with aberrant dopamine (DA) signaling, but it remains unknown whether these deficits result from enhanced DA neuronal activity in the midbrain. Here, we took a novel approach by testing the impact of chemogenetically activating DA neurons in the ventral tegmental area (VTA) or substantia nigra pars compacta (SNc) on attention and impulsivity in the five-choice serial reaction time task (5-CSRTT) in rats. We found that activation of DA neurons in both the VTA and SNc impaired attention by increasing trial omissions. In addition, SNc DA neuron activation decreased attentional accuracy. Surprisingly, enhanced DA neuron activity did not affect impulsive action in this task. These results show that enhanced midbrain DA neuronal activity induces deficits in attentional performance, but not impulsivity. Furthermore, DA neurons in the VTA and SNc have different roles in regulating attention. These findings contribute to our understanding of the neural substrates underlying attention deficits and impulsivity, and provide valuable insights to improve treatment of these symptoms.


Assuntos
Atenção/fisiologia , Neurônios Dopaminérgicos/fisiologia , Comportamento Impulsivo/fisiologia , Desempenho Psicomotor/fisiologia , Substância Negra/fisiologia , Área Tegmentar Ventral/fisiologia , Animais , Comportamento Animal/fisiologia , Drogas Desenhadas , Neurônios Dopaminérgicos/efeitos dos fármacos , Masculino , Ratos , Ratos Long-Evans , Ratos Transgênicos
2.
Neuropsychopharmacology ; 41(9): 2215-23, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-26860202

RESUMO

Social play behavior is a highly rewarding form of social interaction displayed by young mammals. Social play is important for neurobehavioral development and it has been found to be impaired in several developmental psychiatric disorders. In line with the rewarding properties of social play, we have previously identified the nucleus accumbens (NAc) as an important site of action for endocannabinoid and opioid modulation of this behavior. NAc dopamine has a well-known role in certain components of reward processes, such as incentive motivation. However, its contribution to the positive emotional aspects of social interactions is less clear. Therefore, we investigated the role of dopaminergic neurotransmission in the NAc in social play behavior in rats. We found that intra-NAc infusion of the dopamine releaser/reuptake inhibitor amphetamine increased social play behavior that was dependent on activation of both D1 and D2 dopamine receptors. This increase in social play behavior was mimicked by intra-NAc infusion of the dopamine receptor agonist apomorphine, but not of the dopamine reuptake inhibitor GBR-12909. Blockade of either D1 or D2 NAc dopamine receptors reduced social play in animals highly motivated to play as a result of longer social isolation before testing. Last, blockade of NAc dopamine receptors prevented the play-enhancing effects of endocannabinoid and opioid receptor stimulation. These findings demonstrate an important modulatory role of NAc dopaminergic neurotransmission in social play. Thus, functional activity in the mesolimbic dopamine pathway plays an important role in adaptive social development, whereas abnormal NAc dopamine function may underlie the social impairments observed in developmental psychiatric disorders such as autism, attention deficit hyperactivity disorder or early-onset schizophrenia.


Assuntos
Dopamina/fisiologia , Núcleo Accumbens/fisiologia , Comportamento Social , Transmissão Sináptica , Anfetamina/administração & dosagem , Animais , Apomorfina/administração & dosagem , Antagonistas dos Receptores de Dopamina D2/administração & dosagem , Inibidores da Captação de Dopamina/administração & dosagem , Masculino , Motivação/efeitos dos fármacos , Núcleo Accumbens/efeitos dos fármacos , Piperazinas/administração & dosagem , Ratos Wistar , Receptores de Dopamina D1/agonistas , Receptores de Dopamina D1/antagonistas & inibidores , Receptores de Dopamina D2/agonistas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...